- £83.83m
- £84.48m
- £70.61m
- 46
- 46
- 69
- 53
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49.4 | 48 | 59.3 | 72.8 | 70.6 |
Cost of Revenue | |||||
Gross Profit | 12.3 | 13 | 20.2 | 28.6 | 26.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 60.3 | 52.3 | 58 | 71.5 | 72.6 |
Operating Profit | -10.9 | -4.29 | 1.23 | 1.24 | -1.95 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.9 | -4.32 | 0.994 | 0.824 | -2.42 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.4 | -4.37 | 0.695 | 1.79 | -2.17 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -71.3 | -11.7 | 16.2 | 1.63 | -2.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -71.3 | -11.7 | 16.2 | 1.63 | -2.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.146 | -0.024 | 0.042 | 0.028 | -0.029 |
Dividends per Share |